NFE2L2 and neoplasm: NRF2 in combination with its own negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), has become the center of a debate regarding whether NRF2 suppresses the tumor promotion or, conversely, exerts pro-oncogenic functions.